← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Curebiotech, Inc.
Philadelphia, PA
$2,453,662
Total funding
3
Grants
Funding over time
peak $1M · FY2017–22$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,453,662 · 3
By mechanism
R44$1,999,932 · 1
R41$250,876 · 1
R43$202,854 · 1
Investigators at Curebiotech, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma$1,024,973
R44 · FY2019 · CA
Intratumoral immunotherapy with formulated resiquimod for metastatic melanoma$974,959
R44 · FY2020 · CA
Combination of CB101 and radiation therapy in head and neck squamous cell carcinoma$250,876
R41 · FY2022 · CA
Novel injectable resiquimod formulation for treatment of metastatic cancers$202,854
R43 · FY2017 · CA